Promotional Response Modelling (PRM) for Pharma Brands

The Real Problem: You are Spending Without Knowing where Returns Drop A brand team increases rep calls in a key territory. Digital campaigns are also scaled to support the push. On paper, activity looks strong. The field teams are busy. Engagement metrics are healthy. But prescriptions barely move. No one can explain why. The real […]

Pharma Demand Forecasting: What Actually Works in Practice

The Problem: Forecasts Look Precise Until They Break A specialty drug launches strong in the first quarter. Demand spikes above forecast. Supply cannot keep up. By the time production adjusts, competitors have stepped in and early momentum is lost. In another case, a mature brand shows steady historical growth. The forecast holds that trend. Then […]

The AI Revolution in Drug Discovery: Faster Cures On the Horizon

Imagine a world where finding cures isn’t a marathon, but a sprint. Enter Generative AI (GenAI), the wunderkind of the pharmaceutical lab, here to shake things up like a mad scientist with a test tube full of bright ideas. This isn’t your average lab assistant. GenAI’s got superhuman data-crunching abilities, sifting through mountains of research […]

Beyond Time-Series: Applying Systematic, AI-Driven Anomaly Detection in Pharma Data Pipelines

In our previous discussion, we explored how time-series anomaly detection can illuminate hidden patterns and unexpected shifts in complex pharmaceutical sales data. By identifying sudden fluctuations—such as abrupt drops or surges—across time, we gain understanding on market forces, competition dynamics, and prescribing behaviors. When dealing with pharmaceutical commercial data, Many people mistakenly believe that anomaly […]

Revolutionizing Clinical Trials with Data-Driven Precision

In today’s fast-evolving pharmaceutical and biotech sectors, success in clinical trials is increasingly tied to how well companies can harness the power of data. As we push the boundaries of medical innovation, the collaboration with Principal Investigators (PIs) becomes a linchpin in the process. Yet, traditional methods—often hampered by data inadequacies, feasibility delays, and suboptimal […]

Exploring New Frontiers with Reltio’s Data Capabilities in Pharma

In today’s rapidly evolving pharmaceutical landscape, Master Data Management is evolving beyond traditional record-keeping into a strategic enabler of commercial excellence. At Chryselys, we’re leveraging Reltio’s innovative capabilities to transform pharmaceutical commercial operations.Here are several promising areas where we see tremendous potential for innovation. Real-time Data Quality Dashboards: Visibility When It Matters Imagine territory alignment […]